The present invention relates to novel 3-phenyl-3-methoxy-pyrrolidine derivatives, useful for modulating extracellular levels of catecholamines, dopamine and norepinephrine, in cerebral cortical areas of the mammalian brain, and more specifically for the treatment of central nervous system disorders. In other aspects the invention relates to pharmaceutical compositions comprising the 3-phenyl-3-methoxy-pyrrolidine derivatives of the invention and to the use of these compounds for therapeutic applications.
本发明涉及一种新的3-苯基-
3-甲氧基吡咯烷衍
生物,用于调节哺乳动物大脑皮层区域中
儿茶酚、
多巴胺和
去甲肾上腺素的细胞外
水平,更具体地用于治疗中枢神经系统疾病。在其他方面,本发明涉及包含本发明中的3-苯基-
3-甲氧基吡咯烷衍
生物的制药组合物,以及利用这些化合物进行治疗应用的用途。